London, February 8, 2022 – Hikma Pharmaceuticals PLC (Hikma, Group), will announce its preliminary financial results for the year ended 31 December 2021 on Thursday 24 February 2022.
8 February 2022
A recording of the presentation will be available on the Group’s website at www.hikma.com from 7:00am GMT. Hikma will also hold a live Q&A conference call for analysts at 9:30am GMT, and a recording will be made available on the Company’s website.
To join via conference call please dial:
United Kingdom: 0800 640 6441
United Kingdom (local): 020 3936 2999
All other locations: +44 20 3936 2999
Access code: 446040
For further information please contact Tiina Lugmayer – firstname.lastname@example.org.